Thursday, June 24, 2021

Medtech leaders launch FDA-backed initiative to bolster diversity in device development

Vernessa Pollard (center) and Nada Hanafi (right of center) will lead a collaborative community started by MedTech Color to improve diversity in medical devices. Photo credit: MedTech Color As the Food and Drug Administration issues a new guidance for clinical trial diversity, a group of medical technology executives is working with the agency to...

Meet the tech company focused on streamlining state-based insurance exchanges

Affordable Care Act, ACA, exchanges, Obamacare,
With the recent Supreme Court decision to uphold the Affordable Care Act, a streamlined and cost-effective way for Americans to sign up and retain coverage is essential. This is precisely what IT services company IdeaCrew aims to help states — which are not on the federal marketplace — provide for their residents as...

Providers are planning a post-pandemic future with deviceless remote patient monitoring

COVID-19 has hit provider organizations hard with challenges including lost revenue, reduced staff, and uncontrolled chronic conditions while the most critical patients avoid care. Population health leaders, especially those in value-based contracts, face a fourth challenge: rising-risk patients. Under the status quo, providers rely on manual traditional care management and device-based technology that does...

This Is The Best Deal On A Running Watch In The Amazon Prime Day Sale

Those looking to buy a new running watch have been treated to a smörgåsbord of terrific deals in the Amazon Prime Day sale this year, with a host of Garmin devices in particular receiving substantial discounts.Some standout deals included discounts on the budget-friendly Garmin Forerunner 45, reduced to £103 from its RRP of...

Intellia, Cellex form CAR T cell therapy newco backed by $250M from Blackstone

T-cells attacking cancer cell illustration of microscopic photosT-cells attacking cancer cell illustration of microscopic photos
  Gene-editing biotech Intellia Therapeutics is joining forces with Cellex Cell Professionals, launching a new startup that will develop immunotherapies for cancers and inflammatory diseases. That new company will be backed by up to $250 million from Blackstone Life Sciences. This new company aims to improve on the type of cancer immunotherapy called chimeric...

A status report on healthcare’s adoption of digital documents

  A new survey from Foxit Software on the shift to paperless medical documents and processes reveals that the Covid-19 pandemic has given a new sense of urgency for healthcare organizations to shift parts of their business that rely on paper-based documents to digital documents. About 46% of respondents replied “significant” or “urgent”, in...

Mind the Gap: How can we make virtual care fill the mission-critical shoes of primary care for those that need it the most?

While an apple a day may not keep the doctor away, primary care often serves as the first line of defense against “sick” care. By providing patients with a holistic view of their health and wellbeing, primary care is intended to help alleviate more serious health concerns down the road and takes on...

SCOTUS limits patent judges’ power but preserves PTAB review

The United States Supreme Court ruled Monday that the structure of the country’s patent adjudication tribunal was unconstitutional but declined to eradicate it, instead sending the medical device case at issue to the U.S. Patent and Trademark Office director for further review. The case centers on whether the decisions of Administrative Patent Judges (APJs)...

Study: Most health apps designed to capture personal data

Privacy concerns are nothing new to the world of mobile apps. Past research has highlighted a multitude of privacy concerns, including Covid-19 apps sharing data with advertising and analytics firms, or period-tracking apps sharing sensitive health data without users’ consent, though it’s been difficult to quantify the full scope of the problem. An analysis...

Real-world remdesivir data add to body of evidence for Gilead Sciences Covid-19 drug

  The Gilead Sciences drug remdesivir became the first FDA-approved treatment for Covid-19 based on data from three Phase 3 clinical trials enrolling a little more than 2,000 patients. The company now has new real-world data from 98,654 hospitalized patients that lend additional support for use of the drug. According to the studies, treatment...
0FansLike
0FollowersFollow
- Advertisement -

Must Read